F2RL1
Proteinase-activated receptor 2
Also known as: GPR11, PAR2, PAR2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P55085
- Gene
- F2RL1
- Ensembl
- ENSG00000164251
- Chromosome
- 5
- Canonical length
- 397 aa
- Protein class
- G-protein coupled receptors, Predicted membrane proteins, Transporters
- Subcellular location
- Plasma membrane
OverviewNCBI Gene
This gene encodes a member of the G-protein coupled receptor 1 family of proteins. The encoded cell surface receptor is activated through proteolytic cleavage of its extracellular amino terminus, resulting in a new amino terminus that acts as a tethered ligand that binds to an extracellular loop domain. Activation of the receptor has been shown to stimulate vascular smooth muscle relaxation, dilate blood vessels, increase blood flow, and lower blood pressure. This protein is also important in the inflammatory response, as well as innate and adaptive immunity. [provided by RefSeq, Jun 2016]
Canonical amino-acid sequenceUniProt
397 residues, UniProt reviewed canonical sequence.
>P55085|F2RL1
1 MRSPSAAWLL GAAILLAASL SCSGTIQGTN RSSKGRSLIG KVDGTSHVTG KGVTVETVFS
61 VDEFSASVLT GKLTTVFLPI VYTIVFVVGL PSNGMALWVF LFRTKKKHPA VIYMANLALA
121 DLLSVIWFPL KIAYHIHGNN WIYGEALCNV LIGFFYGNMY CSILFMTCLS VQRYWVIVNP
181 MGHSRKKANI AIGISLAIWL LILLVTIPLY VVKQTIFIPA LNITTCHDVL PEQLLVGDMF
241 NYFLSLAIGV FLFPAFLTAS AYVLMIRMLR SSAMDENSEK KRKRAIKLIV TVLAMYLICF
301 TPSNLLLVVH YFLIKSQGQS HVYALYIVAL CLSTLNSCID PFVYYFVSHD FRDHAKNALL
361 CRSVRTVKQM QVSLTSKKHS RKSSSYSSSS TTVKTSYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against F2RL1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 56 nTPM
Expression across tissuesHPA
Tissue
- colon: 56 nTPM
- rectum: 50 nTPM
- duodenum: 43 nTPM
- stomach: 42 nTPM
- small intestine: 39 nTPM
- skin: 37 nTPM
Single-cell type
- foveolar cells: 142 nCPM
- urothelial cells: 135 nCPM
- suprabasal keratinocytes: 122 nCPM
- colonocytes: 112 nCPM
- ocular epithelial cells: 104 nCPM
- enterocytes: 97 nCPM
Immune cell
- neutrophil: 42 nTPM
- basophil: 12 nTPM
- classical monocyte: 10 nTPM
- myeloid DC: 4.7 nTPM
- total PBMC: 4 nTPM
- memory CD4 T-cell: 3.8 nTPM
Brain region
- choroid plexus: 18 nTPM
- midbrain: 4.6 nTPM
- medulla oblongata: 3.7 nTPM
- spinal cord: 2.3 nTPM
- basal ganglia: 2.1 nTPM
- thalamus: 2.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.33
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.49
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- blood coagulation
- cell-cell junction maintenance
- defense response to virus
- establishment of endothelial barrier
- G protein-coupled receptor signaling pathway
- inflammatory response
- innate immune response
- leukocyte migration
- leukocyte proliferation
- mature conventional dendritic cell differentiation
- negative regulation of chemokine production
- negative regulation of insulin secretion
- negative regulation of JNK cascade
- negative regulation of toll-like receptor 3 signaling pathway
- negative regulation of tumor necrosis factor-mediated signaling pathway
- neutrophil activation
- positive regulation of actin filament depolymerization
- positive regulation of canonical NF-kappaB signal transduction
- positive regulation of cell migration
- positive regulation of chemokine production
- positive regulation of chemotaxis
- positive regulation of cytokine production involved in immune response
- positive regulation of cytosolic calcium ion concentration
- positive regulation of eosinophil degranulation
- positive regulation of ERK1 and ERK2 cascade
- positive regulation of glomerular filtration
- positive regulation of GTPase activity
- positive regulation of interleukin-1 beta production
- positive regulation of interleukin-10 production
- positive regulation of interleukin-6 production
- positive regulation of interleukin-8 production
- positive regulation of JNK cascade
- positive regulation of leukocyte chemotaxis
- positive regulation of phagocytosis, engulfment
- positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- positive regulation of positive chemotaxis
- positive regulation of pseudopodium assembly
- positive regulation of renin secretion into blood stream
- positive regulation of Rho protein signal transduction
- positive regulation of superoxide anion generation
- positive regulation of toll-like receptor 2 signaling pathway
- positive regulation of toll-like receptor 3 signaling pathway
- positive regulation of toll-like receptor 4 signaling pathway
- positive regulation of transcription by RNA polymerase II
- positive regulation of type II interferon production
- regulation of blood coagulation
- regulation of canonical NF-kappaB signal transduction
- regulation of chemokine (C-X-C motif) ligand 2 production
- regulation of JNK cascade
- T cell activation involved in immune response
- vasodilation
- positive regulation of neutrophil mediated killing of gram-negative bacterium
Molecular functions
- G protein-coupled receptor activity
- G-protein alpha-subunit binding
- G-protein beta-subunit binding
- protease binding
- signaling receptor activity
- signaling receptor binding
- thrombin-activated receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of F2RL1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads F2RL1 as an antibody target. Whether an autoantibody or antibody against F2RL1 could matter depends on whether native F2RL1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
F2RL1 is annotated at the cell surface, where native F2RL1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label F2RL1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...